DK1393741T3 - Lagerstabil, flydende fibrinogen-formulering - Google Patents

Lagerstabil, flydende fibrinogen-formulering

Info

Publication number
DK1393741T3
DK1393741T3 DK03016766.2T DK03016766T DK1393741T3 DK 1393741 T3 DK1393741 T3 DK 1393741T3 DK 03016766 T DK03016766 T DK 03016766T DK 1393741 T3 DK1393741 T3 DK 1393741T3
Authority
DK
Denmark
Prior art keywords
stable
fibrinogen formulation
liquid fibrinogen
formulation
liquid
Prior art date
Application number
DK03016766.2T
Other languages
English (en)
Inventor
Volker Gawantka
Karlheinz Enssle
Hubert Metzner
Uwe Liebing
Gerhardt Kumpe
Stefan Schulte
Original Assignee
Csl Behring Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=31496745&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK1393741(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Csl Behring Gmbh filed Critical Csl Behring Gmbh
Application granted granted Critical
Publication of DK1393741T3 publication Critical patent/DK1393741T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/39—Connective tissue peptides, e.g. collagen, elastin, laminin, fibronectin, vitronectin, cold insoluble globulin [CIG]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Hematology (AREA)
  • Zoology (AREA)
  • Biomedical Technology (AREA)
  • Diabetes (AREA)
  • Dermatology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Materials For Medical Uses (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
DK03016766.2T 2002-08-13 2003-07-23 Lagerstabil, flydende fibrinogen-formulering DK1393741T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE10237643 2002-08-13
DE10261126A DE10261126A1 (de) 2002-08-13 2002-12-20 Lagerungsstabile, flüssige Fibrinogen-Formulierung

Publications (1)

Publication Number Publication Date
DK1393741T3 true DK1393741T3 (da) 2010-08-09

Family

ID=31496745

Family Applications (1)

Application Number Title Priority Date Filing Date
DK03016766.2T DK1393741T3 (da) 2002-08-13 2003-07-23 Lagerstabil, flydende fibrinogen-formulering

Country Status (11)

Country Link
US (1) US7045601B2 (da)
EP (1) EP1393741B1 (da)
JP (1) JP4824906B2 (da)
KR (1) KR101082769B1 (da)
AT (1) ATE466589T1 (da)
AU (1) AU2003234743B2 (da)
CA (1) CA2437064C (da)
DE (2) DE10261126A1 (da)
DK (1) DK1393741T3 (da)
ES (1) ES2344687T3 (da)
IL (1) IL157360A (da)

Families Citing this family (43)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2403357T3 (es) 2003-12-11 2013-05-17 Isto Technologies Inc. Sistema de cartílago particulado
JP5292533B2 (ja) 2005-08-26 2013-09-18 ジンマー・インコーポレイテッド インプラントおよび関節疾患の治療、置換および治療方法
FR2894831B1 (fr) * 2005-12-16 2008-02-15 Lab Francais Du Fractionnement Colle biologique exempte de thrombine et son utilisation comme medicament.
AU2007334394B2 (en) 2006-12-15 2013-06-06 Lifebond Ltd. Gelatin-transglutaminase hemostatic dressings and sealants
US8163549B2 (en) 2006-12-20 2012-04-24 Zimmer Orthobiologics, Inc. Method of obtaining viable small tissue particles and use for tissue repair
CN101677836A (zh) * 2007-03-30 2010-03-24 斯鲁姆博达因公司 用于制备纤维蛋白胶的含有浓缩纤维蛋白原的组合物和相关系统的制备方法
US20090012629A1 (en) 2007-04-12 2009-01-08 Isto Technologies, Inc. Compositions and methods for tissue repair
WO2008135963A2 (en) * 2007-05-02 2008-11-13 Hemogem Inc. Fibrinogen for treatment of bleeding in trauma and platelet disorders
US8289514B2 (en) * 2008-03-05 2012-10-16 Aggredyne, Inc. Systems for measuring properties of a physiological fluid suspension
EP2987498B1 (en) 2008-05-02 2017-07-05 Laboratoire Français du Fractionnement et des Biotechnologies Treatment of bleeding with low half-life fibrinogen
CN102124058B (zh) 2008-06-18 2014-05-28 生命连结有限公司 改进的交联组合物
EP2293776B8 (de) * 2008-06-23 2016-05-11 Bio-Products & Bio-Engineering Aktiengesellschaft Lagerstabiles, funktionell intaktes virus-inaktiviertes fibrinogen
HUE049023T2 (hu) * 2008-08-15 2020-08-28 Ironwood Pharmaceuticals Inc Linaklotidot tartalmazó, szájon át történõ beadásra szolgáló készítmények
JP2010069031A (ja) * 2008-09-19 2010-04-02 Chemo Sero Therapeut Res Inst シート状フィブリン糊接着剤
GB0818228D0 (en) * 2008-10-06 2008-11-12 Avecia Biolog Ltd Purification process
US8980610B2 (en) 2008-11-20 2015-03-17 Biogen Idec Ma Inc. Arginine inactivation of viruses
WO2011017502A2 (en) * 2009-08-06 2011-02-10 Ironwood Pharmaceuticals, Inc. Linaclotide-containing formulations for oral administration
WO2011077388A1 (en) 2009-12-22 2011-06-30 Lifebond Ltd Modification of enzymatic crosslinkers for controlling properties of crosslinked matrices
UA108636C2 (xx) 2010-02-17 2015-05-25 Пептид
AU2011287215B2 (en) 2010-08-05 2015-09-10 Lifebond Ltd. Dry composition wound dressings and adhesives
RS59978B1 (sr) 2010-08-11 2020-03-31 Ironwood Pharmaceuticals Inc Stabilne formulacije linaklotida
DK2776055T3 (da) 2011-08-17 2017-03-06 Ironwood Pharmaceuticals Inc Behandlinger for gastrointestinale forstyrrelser
KR101127127B1 (ko) * 2011-10-27 2012-03-21 주식회사 녹십자 고농도 피브리노겐 용액의 제조 방법 및 이를 이용한 피브린 실란트 제품의 제조방법
US8900822B2 (en) * 2011-11-21 2014-12-02 Ethicon, Inc. Fibrinogen assay
US20130202675A1 (en) 2012-02-03 2013-08-08 Dynasil Biomedical Corporation Systems and methods for the fabrication of tissue patches
AU2013231321B2 (en) 2012-03-13 2017-05-25 Octapharma Ag Improved process for production of fibrinogen and fibrinogen produced thereby
CN112717125A (zh) 2012-10-03 2021-04-30 瑞士杰特贝林生物制品有限公司 一种纯化蛋白质的方法
US10188965B2 (en) 2012-12-05 2019-01-29 Csl Behring Gmbh Hydrophobic charge induction chromatographic depletion of a protein from a solution
US20140154233A1 (en) 2012-12-05 2014-06-05 Csl Limited Method of purifying therapeutic proteins
US20140178343A1 (en) 2012-12-21 2014-06-26 Jian Q. Yao Supports and methods for promoting integration of cartilage tissue explants
IL230151A0 (en) * 2013-12-24 2014-09-30 Omrix Biopharmaceuticals Ltd One-component fibrin glue containing a polymerization inhibitor
ES2719505T3 (es) 2013-12-27 2019-07-10 Japan Blood Products Organization Línea altamente productora de fibrinógeno recombinante y método para su producción
IL231230A0 (en) * 2014-02-27 2014-08-31 Omrix Biopharmaceuticals Ltd Fibrinogen preparation
IL231792A0 (en) 2014-03-27 2014-08-31 Omrix Biopharmaceuticals Ltd Device and method for the preparation and administration of one-component fibrin glue
EP3331577A4 (en) 2015-08-07 2019-07-17 Xcede Technologies, Inc. ADHESIVE COMPOSITIONS AND ASSOCIATED METHODS
US9540548B1 (en) 2015-08-07 2017-01-10 Xcede Technologies, Inc. Adhesive compositions and related methods
US9833538B2 (en) 2015-08-07 2017-12-05 Xcede Technologies, Inc. Adhesive compositions and related methods
WO2018007767A1 (fr) * 2016-07-06 2018-01-11 Laboratoire Francais Du Fractionnement Et Des Biotechnologies Fibrinogène liquide stable
FR3053592B1 (fr) * 2016-07-06 2020-05-29 Laboratoire Francais Du Fractionnement Et Des Biotechnologies Fibrinogene liquide stable
FR3061020B1 (fr) * 2016-12-22 2019-05-17 Laboratoire Francais Du Fractionnement Et Des Biotechnologies Composition de fibrinogene humain
SG11202000210UA (en) 2017-08-08 2020-02-27 Csl Behring Ag Hemopexin formulations
US11998654B2 (en) 2018-07-12 2024-06-04 Bard Shannon Limited Securing implants and medical devices
CN111956788A (zh) * 2020-09-22 2020-11-20 上海利康瑞生物工程有限公司 一种猪源纤维蛋白原冻干制剂、制备工艺及其应用

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1939075A1 (de) 1968-11-06 1970-06-04 American Standard Inc Auswurfmundstueck fuer Stroemungsmittel
DE3230849A1 (de) * 1982-08-19 1984-02-23 Behringwerke Ag, 3550 Marburg Pasteurisiertes human-fibrinogen (hf) und verfahren zu dessen herstellung
DE3622642A1 (de) * 1986-07-05 1988-01-14 Behringwerke Ag Einkomponenten-gewebekleber sowie verfahren zu seiner herstellung
DE3734923C1 (de) * 1987-10-15 1989-01-26 Biotest Pharma Gmbh Verfahren zur Herstellung einer sterilen Plasmaproteinloesung,die Fibrinogen und den Gerinnungsfaktor XIII enthaelt
DE4202667C1 (da) * 1992-01-29 1993-05-13 Behringwerke Ag, 3550 Marburg, De
FR2686883B1 (fr) * 1992-02-04 1994-05-13 Aquitaine Develop Transf Sanguin Procede de fabrication de fibrinogene de tres haute purete, fibrinogene de tres haute purete obtenu ainsi qu'une composition pharmaceutique le contenant.
JP3867931B2 (ja) * 1993-11-08 2007-01-17 財団法人化学及血清療法研究所 液状フィブリノゲン製剤
US5411885A (en) * 1993-12-17 1995-05-02 New York Blood Center, Inc. Methods for tissue embedding and tissue culturing
US5639940A (en) 1994-03-03 1997-06-17 Pharmaceutical Proteins Ltd. Production of fibrinogen in transgenic animals
SE9501189D0 (sv) 1995-03-31 1995-03-31 Pharmacia Ab Protein formulation
US5925738A (en) * 1995-12-01 1999-07-20 The American National Red Cross Methods of production and use of liquid formulations of plasma proteins
DE19617369A1 (de) * 1996-04-30 1997-11-06 Immuno Ag Lagerstabile Fibrinogen-Präparate
WO1999056797A1 (en) 1998-05-01 1999-11-11 Zymogenetics, Inc. Fully recombinant tissue sealant compositions
WO2001048016A1 (en) 1999-12-23 2001-07-05 Csl Limited Separation of fibrinogen from plasma proteases
DE10012732A1 (de) * 2000-03-18 2001-09-20 Aventis Behring Gmbh Thrombin-Zubereitungen und Verfahren zu ihrer Herstellung
JP4733283B2 (ja) * 2000-03-28 2011-07-27 一般財団法人化学及血清療法研究所 液状フィブリノゲン製剤

Also Published As

Publication number Publication date
IL157360A (en) 2011-12-29
EP1393741A1 (de) 2004-03-03
EP1393741B1 (de) 2010-05-05
JP2004075682A (ja) 2004-03-11
JP4824906B2 (ja) 2011-11-30
AU2003234743B2 (en) 2008-07-31
KR101082769B1 (ko) 2011-11-11
US20050080009A1 (en) 2005-04-14
CA2437064C (en) 2013-06-11
ES2344687T3 (es) 2010-09-03
US7045601B2 (en) 2006-05-16
DE50312689D1 (de) 2010-06-17
CA2437064A1 (en) 2004-02-13
ATE466589T1 (de) 2010-05-15
DE10261126A1 (de) 2004-03-04
IL157360A0 (en) 2004-02-19
AU2003234743A1 (en) 2004-03-04
KR20040015692A (ko) 2004-02-19

Similar Documents

Publication Publication Date Title
DK1393741T3 (da) Lagerstabil, flydende fibrinogen-formulering
BRPI0402760A (pt) Composição microbicida
RS52390B (en) SYNERGISTIC HERBICIDE PREPARATIONS CONTAINING MESOTRION
BR0317715A (pt) Composições e processos de uso de collajolie
SE0100901D0 (sv) New composition
SV2003001144A (es) FORMAS CRISTALINAS DE LA SAL DE CALCIO DEL ACIDO [R-(R*,R*)]-2-(4-FLUOROFENIL)-ß,ô-DIHIDROXI-5-(1-METILETIL)-3-FENIL-4[(FENILAMINO)CARBONIL]-1H-PIRROL-1-HEPTANOICO (2:1) REF. PC430-01FJT
HUP9900152A2 (hu) Alkoholalapú mikrobaellenes kozmetikai készítmény és alkalmazása
BRPI0412684A (pt) compostos ppar-ativos
BR9911579A (pt) Uso de um composto antimicrobiano para desinfecção
IL173059A0 (en) (2s,4s)-4-fluoro-1-[4-fluoro-beta-(4-fluorophenyl)-l-phenylalanyl]-2-pyrrolidinecarbonitrile p-toluenesulfonic acid salt and anhydrous crystalline forms thereof
DE69917201D1 (de) Nf-kappa b inhibitoren, die indanderivate als aktiven bestandteil enthalten
NO307336B1 (no) 2-[(Dihydro)pyrazolyl-3'-oksylmetylen]anilider, anvendelse derav, samt middel inneholdende forbindelsen og mellomprodukter for fremstilling av forbindelsen
DE50202328D1 (de) Amidofunktionelle aminopolydiorganosiloxane
PT1424893E (pt) Mistura fungicida que contem derivados de arilamidina.
BRPI0410555A (pt) preparação sólida
BR0112389A (pt) Pó para condensador
ES2190164T3 (es) Compuestos piretroides y composiciones que los contienen para controlar plagas.
FR2848116B1 (fr) Composition cosmetique comprenant un inhibiteur des metallo-proteinases et un lipopeptide.
BR0210348A (pt) Material polimérico, contendo um ácido latente
ATE318607T1 (de) Heparin-haltiges ophthalmikum
DE60327936D1 (de) Modulatoren von ship-1
DE60101486D1 (de) Verwendung von Polyaminosäurederivate als Konservierungsmittel
EA200401442A1 (ru) Композиция, содержащая яванское цитронелловое масло, и ее применение в качестве репеллента от насекомых
AR046120A1 (es) Fomulaciones fungicidas que contienen cobre
RS51534B (en) NEW COMPOUND OF SINUSOID IF CURRENT INHIBITORS AND CALCIUM INHIBITOR AND PHARMACEUTICAL MIXTURE CONTAINED BY IT